Study participants with no prior use of cannabis were nearly twice as likely to have HPI as compared to subjects with a history of marijuana use.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Mothers with a history of marijuana use were no more likely than non-users to have children with either autism or developmental delays by age five.
Analyses by the FDA and others have consistently reported that unregulated CBD products are of variable purity and may contain adulterants.
Investigators concluded, “Our results show an objective association between the initiation of cannabis therapy and the reduction of both opioid and benzodiazepine prescriptions.”
Nine percent of respondents acknowledged that they had “eliminated job screenings or drug tests” as a way to either attract or keep their employees.”
Researchers affirmed, “Blood THC concentrations and oral fluid THC concentrations … are relatively poor indicators of cannabis-induced impairment.”
Authors concluded, “Daily administration of CBD to patients with a recent diagnosis of COVID-19 did not alter the clinical evolution in the first 28 days of follow-up.”
NORML’s Deputy Director said, “At a time when politics remain acutely polarized, elected officials ought to come together in a bipartisan manner to repeal the failed policy of cannabis prohibition.”